Exploiting the Mutanome for Tumor Vaccination

• Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer

  2024 Molecular Therapy Oncology article Immunology and Microbiology Immunotherapy and Immune Responses Open access

  8

  citations
• Glioma

  2024 Nature Reviews Disease Primers review Medicine Glioma Diagnosis and Treatment

  588

  citations
• Tumor Pigmentation Does Not Affect Light-Activated Belzupacap Sarotalocan Treatment but Influences Macrophage Polarization in a Murine Melanoma Model

  2024 Investigative Ophthalmology & Visual Science article Medicine Photodynamic Therapy Research Studies Open access

  7

  citations
• A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo

  2023 Nature Cancer article Medicine Acute Myeloid Leukemia Research Open access cited by 2 patents

  39

  citations
• MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression

  2023 Frontiers in Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 5 patents

  34

  citations
• Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA

  2022 Cell Reports article Immunology and Microbiology Immunotherapy and Immune Responses Open access

  5

  citations
• Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA

  2022 Cell Reports article Immunology and Microbiology Immunotherapy and Immune Responses Open access

  14

  citations
• Cancer-Specific T Helper Shared and Neo-Epitopes Uncovered by Expression of the MHC Class II Master Regulator CIITA

  2021 SSRN Electronic Journal preprint Immunology and Microbiology Immunotherapy and Immune Responses Open access

  1

  citations

8 results